Literature DB >> 9674792

Altered glucose metabolism in the hippocampal head in memory impairment.

Y Ouchi1, S Nobezawa, H Okada, E Yoshikawa, M Futatsubashi, M Kaneko.   

Abstract

OBJECTIVE: To evaluate the relevance of hypometabolism in the hippocampal head to the pathophysiology of memory impairment.
BACKGROUND: Neurofunctional imaging studies with an image reslicing technique provided by using software suggest that dysfunction of the amygdalohippocampal system causes memory impairment. However, metabolic and morphologic profiles of the whole hippocampal formation have not been evaluated in detail.
METHODS: By tilting the gantry of a high-resolution PET scanner in a plane parallel to the hippocampal longitudinal axis determined beforehand by MRI, we performed quantitative measurement of glucose metabolism in the subdivisions of the hippocampal formation (head, body, tail) in 10 patients of normal intelligence with pure amnesia, in eight patients with AD, and in eight normal subjects.
RESULTS: Although the volumes of the amygdala and hippocampal formation in pure amnesics were not different significantly from those of normal subjects, glucose metabolism in the head of the hippocampus was significantly lower in pure amnesics. In patients with AD, marked hypometabolism was found extending to the amygdala, the hippocampal head, and the parietotemporal cortex, along with amygdalohippocampal atrophy.
CONCLUSION: Hippocampal head dysfunction plays an important role in memory impairment in amnesic patients. Further metabolic impairment over the amygdalohippocampal system and the surrounding association cortex reflects the pathophysiology of AD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9674792     DOI: 10.1212/wnl.51.1.136

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

1.  Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET).

Authors:  M J de Leon; A Convit; O T Wolf; C Y Tarshish; S DeSanti; H Rusinek; W Tsui; E Kandil; A J Scherer; A Roche; A Imossi; E Thorn; M Bobinski; C Caraos; P Lesbre; D Schlyer; J Poirier; B Reisberg; J Fowler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

2.  Towards a circuit-level understanding of hippocampal CA1 dysfunction in Alzheimer's disease across anatomical axes.

Authors:  Arjun V Masurkar
Journal:  J Alzheimers Dis Parkinsonism       Date:  2018-01-09

3.  Early initiation of hormone therapy in menopausal women is associated with increased hippocampal and posterior cingulate cholinergic activity.

Authors:  Yolanda R Smith; Luvina Bowen; Tiffany M Love; Alison Berent-Spillson; Kirk A Frey; Carol C Persad; Nancy K Reame; Robert A Koeppe; Jon-Kar Zubieta
Journal:  J Clin Endocrinol Metab       Date:  2011-08-24       Impact factor: 5.958

4.  Whither the hippocampus? FDG-PET hippocampal hypometabolism in Alzheimer disease revisited.

Authors:  J A Maldjian; C T Whitlow
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-14       Impact factor: 3.825

Review 5.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

Review 6.  Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.

Authors:  Lisa Mosconi; Alberto Pupi; Mony J De Leon
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

7.  Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Susanne G Mueller; Michael W Weiner; Leon J Thal; Ronald C Petersen; Clifford R Jack; William Jagust; John Q Trojanowski; Arthur W Toga; Laurel Beckett
Journal:  Alzheimers Dement       Date:  2005-07       Impact factor: 21.566

8.  Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance.

Authors:  Nikolaos Scarmeas; Christian G Habeck; Eric Zarahn; Karen E Anderson; Aileen Park; John Hilton; Gregory H Pelton; Matthias H Tabert; Lawrence S Honig; James R Moeller; Davangere P Devanand; Yaakov Stern
Journal:  Neuroimage       Date:  2004-09       Impact factor: 6.556

9.  Effect of subthalamic nucleus stimulation during exercise on the mesolimbocortical dopaminergic region in Parkinson's disease: a positron emission tomography study.

Authors:  Takao Nozaki; Kenji Sugiyama; Shunsuke Yagi; Etsuji Yoshikawa; Toshihiko Kanno; Tetsuya Asakawa; Tae Ito; Tatsuhiro Terada; Hiroki Namba; Yasuomi Ouchi
Journal:  J Cereb Blood Flow Metab       Date:  2012-12-05       Impact factor: 6.200

10.  The human parahippocampal region: I. Temporal pole cytoarchitectonic and MRI correlation.

Authors:  X Blaizot; F Mansilla; A M Insausti; J M Constans; A Salinas-Alamán; P Pró-Sistiaga; A Mohedano-Moriano; R Insausti
Journal:  Cereb Cortex       Date:  2010-01-11       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.